Mounjaro
12.5 mg/mL · Injection, Solution
- Prescription only
- GLP-1 Receptor Agonist
- Active substance
- Tirzepatide
- Made by
- Eli Lilly and Company
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
CanadaNo exact match for this strength and form
Netherlands3 matching products
Details
| Made by | Eli Lilly and Company |
|---|---|
| Active substance | Tirzepatide |
| Used in | Digestion, stomach, diabetes and nutrition |
| Strength | 12.5 mg/mL |
| Form | Injection, Solution |
| Route | Subcutaneous |
| Packs | 1 VIAL, MULTI-DOSE in 1 CARTON / 2.4 mL in 1 VIAL, MULTI-DOSE |
| NDC | 0002-4210 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
18 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Injection, Solution18 products
2.5 mg/.5mL2
2.5 mg/.5mL · 2 companies
- 4.17 mg/mL
5 mg/.5mL2
5 mg/.5mL · 2 companies
7.5 mg/.5mL2
7.5 mg/.5mL · 2 companies
- 8.33 mg/mL
10 mg/.5mL2
10 mg/.5mL · 2 companies
- 12.5 mg/mL
12.5 mg/.5mL2
12.5 mg/.5mL · 2 companies
15 mg/.5mL2
15 mg/.5mL · 2 companies
- 16.7 mg/mL
- 20.8 mg/mL
- 25 mg/mL
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.